Dr. Annie-Claude Dubé-Leduc – Oncologist / Hematologist | Greenfield Park, QC

Dr. Annie-Claude Dubé-Leduc is a highly skilled Medical Oncologist and Hematologist, offering expert care in the diagnosis and systemic treatment of both solid tumors and hematologic malignancies. Practicing at Hôpital Charles-Lemoyne in Greenfield Park, QC, she is part of a dedicated healthcare team committed to delivering comprehensive cancer and blood disorder management. Her practice adheres to the high standards set by the Collège des médecins du Québec (CMQ), ensuring that patients receive safe, ethical, and evidence-based care. She offers a broad spectrum of treatment options and supportive services tailored to each patient's unique needs.

Dr. Dubé-Leduc graduated with a Medical Degree in 2019 and has been practicing as a Medical Oncologist and Hematologist for over 5 years. She completed extensive postgraduate training and received certification in Medical Oncology and Hematology, specializing in the management of cancer and blood disorders. Her advanced training enables her to interpret complex diagnostic results and develop personalized treatment plans that align with the latest clinical guidelines and research developments.

Dedicated to providing patient-centered care, Dr. Dubé-Leduc emphasizes a multidisciplinary approach, integrating evidence-based therapies with compassionate support. She is committed to involving patients and their families in decision-making processes and strives to improve outcomes and quality of life. Fluent in French, she ensures clear communication and understanding for her diverse patient community in Greenfield Park and surrounding areas.

Dr. Annie-Claude Dubé-Leduc has expertise in managing a wide range of conditions, including:

Common Cancers (Solid Tumors) Treated

• Ovarian, Uterine (Endometrial), & Cervical Cancers (Gynecologic Oncology - Medical Aspects): Systemic treatment aspects for cancers of the female reproductive system, often in collaboration with gynecologic oncologists or surgeons.
• Lung Cancer (Non-Small Cell & Small Cell): Cancers originating in the lungs, treated with chemotherapy, targeted therapy, immunotherapy, and/or radiation based on type and stage.
• Colorectal Cancer (Colon & Rectal Cancer): Cancer that starts in the colon or rectum, often managed with surgery, chemotherapy, radiation (for rectal), and targeted therapies.

Benign Hematologic (Non-Cancerous Blood) Disorders Managed

• Hemolytic Anemia (e.g., Autoimmune Hemolytic Anemia - AIHA): A disorder in which red blood cells are destroyed faster than the bone marrow can produce them.
• Thrombophilia & Acquired Clotting Disorders (e.g., DVT/PE management, Antiphospholipid Syndrome): Conditions that increase the tendency to form blood clots, requiring anticoagulation therapy and management.
• Iron Deficiency Anemia: A common type of anemia caused by insufficient iron, leading to reduced red blood cell production and oxygen-carrying capacity.

Hematologic Malignancies (Blood Cancers) Treated

• Myelodysplastic Syndromes (MDS): A group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy, mature blood cells.
• Hodgkin Lymphoma: A cancer of the lymphatic system, part of the immune system, characterized by the presence of Reed-Sternberg cells.
• Waldenström's Macroglobulinemia: A rare type of non-Hodgkin lymphoma characterized by an overproduction of a protein called macroglobulin.

This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Annie-Claude Dubé-Leduc or your referring physician.

• Second Opinion Consultations for Cancer & Blood Disorders: Providing expert second opinions on complex diagnoses and proposed treatment plans to ensure informed decision-making.
• Interpretation of Special Hematologic Tests (e.g., Flow Cytometry, Cytogenetics, Molecular Studies): Analyzing results from advanced laboratory tests crucial for diagnosing and classifying hematologic conditions.
• Management of Treatment-Related Side Effects & Toxicities: Proactive and reactive strategies to manage side effects of cancer therapies, including nausea, fatigue, myelosuppression, and neuropathy.
• Therapeutic Apheresis Consultation (e.g., for TTP, plasma exchange indications): Consultation and coordination for procedures that separate components of blood for therapeutic purposes.
• Comprehensive Diagnosis & Management of Anemias: Investigating and treating various types of anemia, such as iron deficiency, vitamin B12/folate deficiency, hemolytic anemias (e.g., autoimmune hemolytic anemia), sickle cell disease, thalassemia, and aplastic anemia.
• Performance Status Assessment & Treatment Eligibility Evaluation: Evaluating a patient's overall fitness and ability to tolerate specific anti-cancer treatments.
• Management of Clotting Disorders / Thrombophilia (Inherited & Acquired): Diagnosis, anticoagulation therapy, and long-term management for conditions predisposing to abnormal blood clots (e.g., DVT, PE, Factor V Leiden, Antiphospholipid Syndrome).

Note: This list provides a general overview of services offered in Medical Oncology and Hematology (Cancer and Blood Disorders). Treatment plans are highly individualized. Dr. Dubé-Leduc provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Dubé-Leduc or your healthcare team for details relevant to your care.

All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.

Dr. Dubé-Leduc practices primarily at the Hôpital Charles-Lemoyne, situated in the areas near central Greenfield Park. The hospital is conveniently accessible via local public transit, with nearby bus stops and parking facilities. The facility is wheelchair accessible, ensuring ease of access for all patients. Parking is available at the hospital, making it straightforward for patients to attend appointments without concern for transportation logistics. The hospital is close to local points of interest, such as shopping centers and community services, providing a comfortable environment for patients and visitors alike.

Are consultations and treatments with Dr. Dubé-Leduc, an Medical Oncologist and Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?

Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Medical Oncologist and Hematologist such as Dr. Dubé-Leduc are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Dubé-Leduc's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.

Do I need a referral to see Dr. Dubé-Leduc, an Medical Oncologist and Hematologist?

Yes, a referral from your family physician or another specialist is almost always required to see an Medical Oncologist and Hematologist like Dr. Dubé-Leduc for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.

What is Radiation Oncology and when is it used?

Radiation Oncology is a medical specialty that uses high-energy radiation (like X-rays, gamma rays, or charged particles) to damage or destroy cancer cells and shrink tumors. It can be used as a primary treatment, before surgery (neoadjuvant), after surgery (adjuvant), or in combination with chemotherapy. It can also be used for palliative care to relieve symptoms. [If Dr. Dubé-Leduc is a radiation oncologist:] Dr. Dubé-Leduc specializes in planning and delivering radiation therapy using techniques like EBRT, IMRT, SBRT, or brachytherapy. [Else:] Dr. Dubé-Leduc may refer patients to a Radiation Oncologist if this treatment is indicated for their type of cancer as part of a multidisciplinary care plan.

What are common side effects of chemotherapy, and how does Dr. Dubé-Leduc help manage them?

Chemotherapy can cause various side effects, which differ depending on the specific drugs used, the dose, and individual patient factors. Common ones include fatigue, nausea, vomiting, hair loss, mouth sores, changes in appetite, diarrhea or constipation, and increased risk of infection due to low blood counts. Dr. Dubé-Leduc and the oncology nursing team will discuss potential side effects of your specific treatment plan in detail and will actively work to prevent and manage them with medications (e.g., anti-nausea drugs, growth factors to boost blood counts), supportive care advice (nutrition, hydration, rest), and regular monitoring. Open communication about any side effects you experience is very important for effective management.

Does Dr. Dubé-Leduc participate in or offer access to clinical trials?

Many oncologists and hematologists are involved in clinical research to advance cancer treatment and care for blood disorders, as participation in clinical trials can offer access to new and investigational treatments. [If Dr. Dubé-Leduc is involved:] Dr. Dubé-Leduc is actively involved in clinical trials and may discuss relevant trial options with you if you are eligible and it is appropriate for your condition. [Else:] You can ask Dr. Dubé-Leduc if there are any suitable clinical trials available for your condition, either at her institution or through collaborative research networks. She can provide information or refer you for consideration.

Hôpital Charles-Lemoyne
3120 Boul Taschereau
Greenfield Park, QC J4V 2H1

Phone: (450) 466-5000 | Fax: (450) 466-5066

The facility is wheelchair accessible.

Dr. Dubé-Leduc is a licensed Medical Oncologist and Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.

Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=19836